Unraveling the complex biology of autism spectrum disorder

Notice: Blog posts are not subject to review by MedLink Neurology’s Editorial Board.

Author: Joaquin A Pena MD

Introduction

Autism spectrum disorder is recognized as a set of heterogeneous neurodevelopmental conditions, characterized by difficulties in social interaction and communication, and restricted, repetitive behaviors. Autism spectrum disorder presents with significant individual differences and a complex etiology. Current research, which is crucial for advancing our understanding of the brain's function and its impact on behavior, is dedicated to understanding the underlying biological mechanisms contributing to its pathogenesis, highlighting the critical roles of genetics, changes in brain structure and function, neuroinflammation, synaptic alterations, mitochondrial dysfunction, and the gut-brain axis.

Understanding the biological foundations

Genetic insights. Autism spectrum disorder has a broad genetic variability and is thought to originate from a polygenic basis, with a significant genetic component often exacerbated by environmental factors. Studies indicate that the heritability of autism spectrum disorder risk is substantial, estimated between 74% and 93%. Rare and de novo mutations are considered key contributors to the etiology of autism spectrum disorder, including de novo coding mutations. Both inherited and de novo genetic risk factors appear to impact shared biological networks. Analysis of gene clusters highlights those associated with synaptic transmission, neuronal development, and chromatin regulation as affected by genetic variation. Transcriptomic studies have revealed dysregulation of innate immune response genes and neuronal activity-dependent genes in the autistic brain, showing a convergent molecular pathology. Specific genes that have been implicated include CACNA1A, SynGAP, and SHANK.

Neurobiological mechanisms. Autism spectrum disorder involves disruptions in neurodevelopmental processes.

Neuroinflammation and glial cell dysfunction. Neuroglial activation and neuroinflammation have been documented in the brains of individuals with autism. Microglia are known to modulate neurodevelopment, and aberrant synaptic pruning carried out by microglia may contribute to altered neuronal architecture in autism spectrum disorder. For instance, abnormal spatial organization between microglia and neurons has been observed in the dorsolateral prefrontal cortex. Inflammation is recognized as a factor contributing to autism spectrum disorder. Disruptions in oligodendrocyte-driven myelination and the glutamate modulation by astrocytes also play roles.

Synaptic and circuitry alterations. Synaptic structures are early and critical targets in autism spectrum disorder. Synaptic dysfunction is a prominent feature involved in autism spectrum disorder. There is evidence for an excitation and inhibition imbalance in animal models of autism spectrum disorder. Alterations at dendritic fibers, specifically in flat and spine response sites, contribute to these excitation and inhibition effects. Proteins like SHANK are essential at the synapse and are implicated in autism spectrum disorder, as is SynGAP, linking synaptic function to cognition.

Mitochondrial dysfunction. Metabolic profiles of individuals with autism spectrum disorder suggest a potential involvement of mitochondrial pathways. Physiological and biochemical studies have reported deficits in mitochondrial oxidative phosphorylation. Mitochondrial abnormalities have been identified in the temporal lobe of the autistic brain, and mitochondrial dysfunction is proposed as a neurobiological subtype of autism spectrum disorder, supported by brain imaging.

The cerebellum's role. The cerebellum plays a critical role in autism spectrum disorder. During the perinatal and early postnatal periods, the cerebellum experiences substantial growth and structural refinement, which includes granule cell migration, Purkinje cell dendritic arborization, and synaptogenesis. Studies have found altered cerebellar connectivity and deficits in cerebellum-dependent associative sensory learning in mouse models of autism. Correlations have been noted between cerebellar gray matter, lobular volumes, and core autism symptoms. Histopathological findings include reduced Purkinje cell size and density in the cerebellum of patients with autism. Exposure to valproic acid prenatally, which increases autism spectrum disorder risk, is associated with dysregulation of autism-linked genes in the developing cerebellum.

Brain connectivity patterns. Research shows altered functional connectivity between the cerebellum and visual and sensory-motor networks. Increased functional connectivity between subcortical and cortical resting-state networks has also been reported. Atypical cerebellar functional connectivity observed as early as 9 months of age can predict later delayed socio-communicative profiles in infants at varying levels of risk for autism.

The intriguing gut-brain axis connection. The relationship between metabolism, mitochondria, and the microbiome has been linked to autism. Autism spectrum disorder is sometimes conceptualized as a disorder involving the brain-gut-microbiome axis. Evidence points to altered gut microbiota in individuals with autism spectrum disorder, including a reduced incidence of Prevotella and other fermenters. Differences in fecal microbiota and metabolome profiles have been observed in autistic children. Animal studies show that the microbial metabolite p-Cresol can induce autistic-like behaviors in mice. Evaluations of intestinal function have been conducted in children with autism spectrum disorder who also have gastrointestinal symptoms. Alterations in both the blood-brain barrier and the intestinal epithelial barrier are observed in autism spectrum disorder. Although crucial for autism research, this field is not yet fully developed.

References

Bala M, Ali MH, Satu MS, Hasan KF, Moni MA. Efficient machine learning models for early stage detection of autism spectrum disorder. Algorithms 2022;15(5):166.

Citrigno L, Muglia M, Qualtieri A, et al. The mitochondrial dysfunction hypothesis in autism spectrum disorders: current status and future perspectives. Int J Mol Sci 2020;21(16):5785. PMID 32806635

Fan G, Ma J, Ma R, et al. Microglia modulate neurodevelopment in autism spectrum disorder and schizophrenia. Int J Mol Sci 2023;24(24):17297. PMID 38139124

Guerra M, Medici V, La Sala G, Farini D. Unravelling the cerebellar involvement in autism spectrum disorders: insights into genetic mechanisms and developmental pathways. Cells 2024;13(14):1176. PMID 39056758

Ilic N, Larajlija B. Pathogenetic understandings, genetic threads, and therapeutic prospects of neuroglial dysregulation in autism spectrum disorder. Adv Behav Neurosci 2025;1(1).

Jiang M, Lu T, Yang K, et al. Autism spectrum disorder research: knowledge mapping of progress and focus between 2011 and 2022. Front Psychiatry 2023;14:1096769. PMID 37181872

Lamanna J, Meldolesi J. Autism spectrum disorder: brain areas involved, neurobiological mechanisms, diagnoses and therapies. Int J Mol Sci 2024;25(4):2423. PMID 38397100

Qin L, Wang H, Ning W, Cui M, Wang Q. New advances in the diagnosis and treatment of autism spectrum disorders. Eur J Med Res 2024;29(1):322. PMID 38858682

Related MedLink Neurology Blog content:

• Innovations in identifying and supporting individuals on the autism spectrum

Are you interested in contributing a post or becoming a guest blogger for MedLink? Contact us at editorial@medlink.com.